Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor–Induced Musculoskeletal Pain: SWOG S0927

PURPOSE: Musculoskeletal symptoms are the most common adverse effects of aromatase inhibitors (AIs) and can result in decreased quality of life and discontinuation of therapy. Omega-3 fatty acids (O3-FAs) can be effective in decreasing arthralgia resulting from rheumatologic conditions and reducing...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Oncol
Asıl Yazarlar: Hershman, Dawn L., Unger, Joseph M., Crew, Katherine D., Awad, Danielle, Dakhil, Shaker R., Gralow, Julie, Greenlee, Heather, Lew, Danika L., Minasian, Lori M., Till, Cathee, Wade, James L., Meyskens, Frank L., Moinpour, Carol M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2015
Konular:
ORIGINAL REPORTS
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4451174/
https://ncbi.nlm.nih.gov/pubmed/25940724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.59.5595
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller